At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
From VHIO´s Director and WIN Symposium Chair: Josep Tabernero´s Paris Preview
As Chair of the 2016 annual two-day WIN (Worldwide Innovative Network) Symposium: Innovative Approaches to Improve Cancer Patient Outcomes, to be…
17 Jun 2016
Pertuzumab adds 16 months survival benefit to trastuzumab and chemotherapy treatment for HER2-positive metastatic breast cancer
Long-term follow-up from CLEOPATRA study presented at ESMO 2014 demonstrates ‘unprecedented’ benefit Lugano/Madrid, 28 September 2014 — Patients with HER2-positive…
29 Sep 2014
Aggressiveness of breast cancer associated with longer lead times to metastasis
• Latest findings published in Cancer Research reveal that Luminal A breast cancer can switch subtype during time to metastasis…
24 Apr 2017
VHIO on the ground presenting at this year´s ASCO Annual Meeting: a hand-pick of highlights
Many of VHIO´s leading clinical investigators are currently participating at the 2017 Annual Meeting of the American Society of Clinical…
03 Jun 2017
VHIO on the ground and delivering data at San Antonio Breast Cancer Symposium 2016
Now in its 39th annual edition, the San Antonio Breast Cancer Symposium (SABCS) is the world´s largest, multidisciplinary breast cancer…
08 Dec 2016
VHIO genomic study identifies subgroups of HER2+ breast cancer with varying sensitivities to anti-HER2 treatment
• VHIO describes as many as four subgroups of HER2+ breast cancer (Luminal A, Luminal B, HER2-enriched and Basal-Like) with…
17 Jan 2014
Breast cancer diagnosed during pregnancy: safely treatable without harming foetal development
Cristina Saura, Principal Investigator of VHIO´s Breast Cancer and Melanoma Group, today reported important findings during her thesis defence directed…
21 Jul 2017
Grant for the research in colorectal cancer
The “Olga Torres” Foundation awards to a VHIO research group a grant for the research on tumor stem cells
07 Sep 2010
El Corte Inglés – AECC alliance: championing translational breast cancer research of excellence
In celebration of World Breast Cancer Day, the Spanish retailer El Corte Inglés and the Spanish Association against Cancer (AECC)…
19 Oct 2017
Joan Seoane awarded for exceptional contribution to translational cancer science and medicine
Barcelona, 28 January 2015. Today marks an important date in the diary for Joan Seoane, Director of Translational Research at…
28 Jan 2015
VHIO participation at AACR´s Annual Meeting 2014
Barcelona, April 11, 2014. Preclinical, translational and clinical researchers and physician-scientists from the Vall d’Hebron Institute of Oncology (VHIO) attended…
14 Apr 2014
VHIO faculty: making a splash in ESMO´s digital magazine, ESMO Perspectives
Launched in December last year, the European Society of Medical Oncology´s (ESMO) digital magazine – accessible to members and non-members…
18 Sep 2017
04 February: THE international day against cancer
World Cancer Day is the singular initiative under which the UICC (Union for International Cancer Control), its members, partners, supporters…
29 Jan 2014
´We can. I can´: Today 04 February is World Cancer Day
Today´s World Cancer Day (WCD) marks the launch of a new three-year campaign led by the Union for International Cancer…
04 Feb 2016
The promise of novel bispecific antibody for patients with heavily-pretreated metastatic colorectal cancer: VHIO´s Guillem Argilés discusses preliminary data showing efficacy and favorable safety profile
During a Selected Abstracts Session entitled New Drugs in GI Cancer and Abstracts on Non-Colorectal Cancer at the recent European…
11 Jul 2017
